SummaryGABAC (ρ) receptors are members of the Cys-loop superfamily of neurotransmitter receptors, which includes nicotinic acetylcholine (nACh), 5-HT3, and glycine receptors. As in other members of this family, the agonist binding site of GABAC receptors is rich in aromatic amino acids, but while other receptors bind agonist through a cation-π interaction to a tryptophan, the GABAC binding site has tyrosine at the aligning positions. Incorporating a series of tyrosine derivatives at position 198 using unnatural amino acid mutagenesis reveals a clear correlation between the cation-π binding ability of the side chain and EC50 for receptor activation, thus demonstrating a cation-π interaction between a tyrosine side chain and a neurotransmitte...
Drug-receptor binding interactions of four agonists, ACh, nicotine, and the smoking cessation compou...
© 2014 Dr. Lik Wei WongThe GABAA receptor and closely related GABAC receptor are members of the pent...
The α7 nicotinic acetylcholine receptor (nAChR) is a potential drug target for the treatment of a nu...
SummaryGABAC (ρ) receptors are members of the Cys-loop superfamily of neurotransmitter receptors, wh...
Cys-loop receptor binding sites characteristically contain many aromatic amino acids. In nicotinic A...
The ligand binding site of Cys-loop receptors is dominated by aromatic amino acids. In GABA_C recept...
Cation-π interactions have been demonstrated to play a major role in agonist-binding in Cys-loop rec...
The nicotinic acetylcholine receptor (nAChR) is a ligand gated ion channel and a member of the Cys-l...
Throughout the central nervous system (CNS), the Cys-loop superfamily of ligand-gated ion channels {...
Binding of the agonist GABA to the GABAA receptor causes channel gating, whereas competitive antagon...
Cys-loop ligand gated ion channels mediate rapid synaptic transmission in the mammalian central and ...
Ligands acting on receptors are considered to induce a conformational change within the ligand-bindi...
The cation-π interaction [1,2] is a potent, noncovalent binding force that is quite prominent in str...
Cys-loop receptor binding sites characteristically possess an "aromatic box," where several aromatic...
A series of tryptophan analogues has been introduced into the binding site regions of two ion channe...
Drug-receptor binding interactions of four agonists, ACh, nicotine, and the smoking cessation compou...
© 2014 Dr. Lik Wei WongThe GABAA receptor and closely related GABAC receptor are members of the pent...
The α7 nicotinic acetylcholine receptor (nAChR) is a potential drug target for the treatment of a nu...
SummaryGABAC (ρ) receptors are members of the Cys-loop superfamily of neurotransmitter receptors, wh...
Cys-loop receptor binding sites characteristically contain many aromatic amino acids. In nicotinic A...
The ligand binding site of Cys-loop receptors is dominated by aromatic amino acids. In GABA_C recept...
Cation-π interactions have been demonstrated to play a major role in agonist-binding in Cys-loop rec...
The nicotinic acetylcholine receptor (nAChR) is a ligand gated ion channel and a member of the Cys-l...
Throughout the central nervous system (CNS), the Cys-loop superfamily of ligand-gated ion channels {...
Binding of the agonist GABA to the GABAA receptor causes channel gating, whereas competitive antagon...
Cys-loop ligand gated ion channels mediate rapid synaptic transmission in the mammalian central and ...
Ligands acting on receptors are considered to induce a conformational change within the ligand-bindi...
The cation-π interaction [1,2] is a potent, noncovalent binding force that is quite prominent in str...
Cys-loop receptor binding sites characteristically possess an "aromatic box," where several aromatic...
A series of tryptophan analogues has been introduced into the binding site regions of two ion channe...
Drug-receptor binding interactions of four agonists, ACh, nicotine, and the smoking cessation compou...
© 2014 Dr. Lik Wei WongThe GABAA receptor and closely related GABAC receptor are members of the pent...
The α7 nicotinic acetylcholine receptor (nAChR) is a potential drug target for the treatment of a nu...